Tumor Stroma Interactions

The Tumor Stroma Interactions group studies the mechanisms leading to leukemia progression. 

Activities

The Tumor Stroma Interactions research group is a dynamic and multinational team studying the mechanisms leading to leukemia progression with the goal to identify new prognostic markers and therapeutic targets. 

Some of the group’s research projects include: 

  • Exosomes in B-cell malignancies – to identify potential biomarkers in exosomes derived from murine preclinical models and cells of patients affected by hematologic malignancies and to test their influence on cells from the microenvironment. 
  • Tumor immunology – to identify new cellular populations which could be used as biomarkers for the response to treatment and potential new therapeutic targets. 
  • New therapeutic targets in CLL – to investigate the therapeutic efficacy and mode of action of new molecules inhibiting translation machinery and prohibitins in chronic lymphocytic leukemia (CLL), both in patient cells and in a murine model. 

Group Leaders

Etienne
Moussay
JÉRÔME
Paggetti

Collaborations

Projects & clinical trials

Featured team members

  • Rafael
    Barros
    PhD Student
  • Michaela
    Bauer
    Postdoctoral Fellow
  • Chloé
    Duculty
    PhD Student
  • Iria
    Fernandez Botana
    Postdoctoral Fellow
  • Alicia
    Garcia Gimenez
    Postdoctoral Fellow
  • Ozgu
    Gumustekin
    PhD Student
  • Vanessa
    Klapp
    PhD Student
  • Anne
    Largeot
    Scientist

Scientific publications

Related News

Tumor Stroma Interactions Researcher Secures Marie Curie Fellowship for Cancer Immunotherapy Study

Tumor Stroma Interactions scientist co-authors study on novel leukemia treatment

The Plooschter Projet continues to support the LIH

Job vacancies

There are no jobs matching this page at the moment. You can view all jobs via the button below.

Make a donation